NCD Alliance / NEWS & EVENTS / News
News
Get all of the NCD Alliance latest news.
Subscribe to our email newsletter for weekly updates.
Get all of the NCD Alliance latest news.
Subscribe to our email newsletter for weekly updates.
Announcements | 27th February 2023
The Africa Regional Advocacy Agenda of People Living with NCDs was launched on 23 February 2023 at a virtual multi-stakeholder event attended by over 70 people, including representatives from the Africa Centres for Disease Control and Prevention (Africa CDC), World Health Organization (WHO), civil society organisations (CSOs) and people living with NCDs from across the region.
Feature | 21st February 2023
New reports are damning the formula milk industry’s aggressive marketing tactics, with one by The British Medical Journal (BMJ) finding that producers are making health claims for their products, in comparison to breast milk, that in most cases are not backed by science.
Feature | 13th February 2023
Mexico’s Parliament has banned the use of trans fats, a common ingredient in processed foods and a major cause of cardiovascular disease and stroke in the country and worldwide.
Announcements | 06th February 2023
Today, at the 152nd session of the Executive Board meetings, the 34 members of the World Health Organization (WHO) Executive Board voted to grant the NCD Alliance (NCDA) official relations status with WHO.
Announcements | 31st January 2023
The civil society staus report assesses the national response to NCDs and aims to complement the government's efforts in addressing the growing burden of NCDs in the country. The report highlights progress made, noted gaps, and recommends actions to reduce the burden of NCDs in Ghana.
Announcements | 30th January 2023
Ahead of the meeting, NCD Alliance published its Advocacy Briefing, which provides background on EB152 along with key advocacy messages on NCD-relevant items from the NCD civil society community on the provisional agenda.
Feature | 04th January 2023
Civil society organizations welcome the expulsion of tobacco giant Philip Morris from Medicago Inc, the corporation involved in Canada's major government-backed COVID-19 vaccine collaboration.
Announcements | 12th December 2022